# Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts

> **NCT05291845** · PHASE2 · RECRUITING · sponsor: **Zagazig University** · enrollment: 162 (estimated)

## Conditions studied

- Warts
- Human Papilloma Virus

## Interventions

- **BIOLOGICAL:** Candida antigen vaccine
- **BIOLOGICAL:** Bivalent HPV vaccine

## Key facts

- **NCT ID:** NCT05291845
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-03
- **Primary completion:** 2025-10-03
- **Final completion:** 2025-12-06
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05291845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05291845, "Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05291845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*